Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats

G. Sharma, K. Wilson, C. F. van der Walle, N. Sattar, J. R. Petrie, M. N. V. Ravi Kumar

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Insulin loaded microemulsions were developed adopting a low shear reverse micellar approach using didoceyldimethylammonium bromide (DMAB) as the surfactant, propylene glycol (PG) as the co-surfactant, triacetin (TA) as the oil phase and insulin solution as the aqueous phase. A ternary phase diagram was constructed based on multiple cloud point titration to highlight the reverse micellar region. The droplet sizes of the microemulsions were 161.7 +/- 24.7 nm with PDI of 0.447 +/- 0.076 and insulin entrapment of similar to 85%. Transmission electron microscopy (TEM) revealed the spherical nature and size homogeneity of the microemulsion droplets. The conformational stability of the entrapped insulin within microemulsions was confirmed by fluorescence spectroscopy and circular dichroism. The microemulsions displayed a 10-fold enhancement in bioavailability compared with plain insulin solution administered per oral in healthy rats. The short-term in vivo efficacy in STZ induced diabetic rats provided the proof of concept by a modest glucose reduction at a dose of 20 IU/kg. Together this preliminary data indicate the promise of microemulsions for oral delivery of insulin. (C) 2010 Elsevier B.V. All rights reserved.

LanguageEnglish
Pages159-169
Number of pages11
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume76
Issue number2
Early online date22 Jul 2010
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Streptozocin
Insulin
Surface-Active Agents
Triacetin
Propylene Glycol
Fluorescence Spectrometry
Circular Dichroism
Transmission Electron Microscopy
Bromides
Biological Availability
Oils
Glucose

Keywords

  • bioavailability
  • insulin
  • microemulsions
  • oral delivery
  • pharmacokinetics
  • reverse micelles
  • intestinal-absorption
  • drug-delivery
  • nano-emulsions
  • degradation
  • nanoparticles
  • systems
  • solubilization
  • nanocapsules

Cite this

Sharma, G. ; Wilson, K. ; van der Walle, C. F. ; Sattar, N. ; Petrie, J. R. ; Kumar, M. N. V. Ravi. / Microemulsions for oral delivery of insulin : design, development and evaluation in streptozotocin induced diabetic rats. In: European Journal of Pharmaceutics and Biopharmaceutics. 2010 ; Vol. 76, No. 2. pp. 159-169.
@article{b492dffd017f4e2d8bede9ce60e86613,
title = "Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats",
abstract = "Insulin loaded microemulsions were developed adopting a low shear reverse micellar approach using didoceyldimethylammonium bromide (DMAB) as the surfactant, propylene glycol (PG) as the co-surfactant, triacetin (TA) as the oil phase and insulin solution as the aqueous phase. A ternary phase diagram was constructed based on multiple cloud point titration to highlight the reverse micellar region. The droplet sizes of the microemulsions were 161.7 +/- 24.7 nm with PDI of 0.447 +/- 0.076 and insulin entrapment of similar to 85{\%}. Transmission electron microscopy (TEM) revealed the spherical nature and size homogeneity of the microemulsion droplets. The conformational stability of the entrapped insulin within microemulsions was confirmed by fluorescence spectroscopy and circular dichroism. The microemulsions displayed a 10-fold enhancement in bioavailability compared with plain insulin solution administered per oral in healthy rats. The short-term in vivo efficacy in STZ induced diabetic rats provided the proof of concept by a modest glucose reduction at a dose of 20 IU/kg. Together this preliminary data indicate the promise of microemulsions for oral delivery of insulin. (C) 2010 Elsevier B.V. All rights reserved.",
keywords = "bioavailability, insulin, microemulsions, oral delivery, pharmacokinetics, reverse micelles, intestinal-absorption, drug-delivery, nano-emulsions, degradation, nanoparticles, systems, solubilization, nanocapsules",
author = "G. Sharma and K. Wilson and {van der Walle}, {C. F.} and N. Sattar and Petrie, {J. R.} and Kumar, {M. N. V. Ravi}",
year = "2010",
month = "10",
doi = "10.1016/j.ejpb.2010.07.002",
language = "English",
volume = "76",
pages = "159--169",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
number = "2",

}

Microemulsions for oral delivery of insulin : design, development and evaluation in streptozotocin induced diabetic rats. / Sharma, G.; Wilson, K.; van der Walle, C. F.; Sattar, N.; Petrie, J. R.; Kumar, M. N. V. Ravi.

In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 76, No. 2, 10.2010, p. 159-169.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Microemulsions for oral delivery of insulin

T2 - European Journal of Pharmaceutics and Biopharmaceutics

AU - Sharma, G.

AU - Wilson, K.

AU - van der Walle, C. F.

AU - Sattar, N.

AU - Petrie, J. R.

AU - Kumar, M. N. V. Ravi

PY - 2010/10

Y1 - 2010/10

N2 - Insulin loaded microemulsions were developed adopting a low shear reverse micellar approach using didoceyldimethylammonium bromide (DMAB) as the surfactant, propylene glycol (PG) as the co-surfactant, triacetin (TA) as the oil phase and insulin solution as the aqueous phase. A ternary phase diagram was constructed based on multiple cloud point titration to highlight the reverse micellar region. The droplet sizes of the microemulsions were 161.7 +/- 24.7 nm with PDI of 0.447 +/- 0.076 and insulin entrapment of similar to 85%. Transmission electron microscopy (TEM) revealed the spherical nature and size homogeneity of the microemulsion droplets. The conformational stability of the entrapped insulin within microemulsions was confirmed by fluorescence spectroscopy and circular dichroism. The microemulsions displayed a 10-fold enhancement in bioavailability compared with plain insulin solution administered per oral in healthy rats. The short-term in vivo efficacy in STZ induced diabetic rats provided the proof of concept by a modest glucose reduction at a dose of 20 IU/kg. Together this preliminary data indicate the promise of microemulsions for oral delivery of insulin. (C) 2010 Elsevier B.V. All rights reserved.

AB - Insulin loaded microemulsions were developed adopting a low shear reverse micellar approach using didoceyldimethylammonium bromide (DMAB) as the surfactant, propylene glycol (PG) as the co-surfactant, triacetin (TA) as the oil phase and insulin solution as the aqueous phase. A ternary phase diagram was constructed based on multiple cloud point titration to highlight the reverse micellar region. The droplet sizes of the microemulsions were 161.7 +/- 24.7 nm with PDI of 0.447 +/- 0.076 and insulin entrapment of similar to 85%. Transmission electron microscopy (TEM) revealed the spherical nature and size homogeneity of the microemulsion droplets. The conformational stability of the entrapped insulin within microemulsions was confirmed by fluorescence spectroscopy and circular dichroism. The microemulsions displayed a 10-fold enhancement in bioavailability compared with plain insulin solution administered per oral in healthy rats. The short-term in vivo efficacy in STZ induced diabetic rats provided the proof of concept by a modest glucose reduction at a dose of 20 IU/kg. Together this preliminary data indicate the promise of microemulsions for oral delivery of insulin. (C) 2010 Elsevier B.V. All rights reserved.

KW - bioavailability

KW - insulin

KW - microemulsions

KW - oral delivery

KW - pharmacokinetics

KW - reverse micelles

KW - intestinal-absorption

KW - drug-delivery

KW - nano-emulsions

KW - degradation

KW - nanoparticles

KW - systems

KW - solubilization

KW - nanocapsules

UR - http://www.scopus.com/inward/record.url?scp=77957285711&partnerID=8YFLogxK

U2 - 10.1016/j.ejpb.2010.07.002

DO - 10.1016/j.ejpb.2010.07.002

M3 - Article

VL - 76

SP - 159

EP - 169

JO - European Journal of Pharmaceutics and Biopharmaceutics

JF - European Journal of Pharmaceutics and Biopharmaceutics

SN - 0939-6411

IS - 2

ER -